Literature DB >> 18538345

Reversible focal neurological deficits in systemic lupus erythematosus: report of 2 cases and review of the literature.

Miho Kimura1, Kaori Aramaki, Tatsuhiko Wada, Kazuo Nishi, Reiko Matsushita, Nobuko Iizuka, Atsushi Hashimoto, Sumiaki Tanaka, Akira Ishikawa, Hirahito Endo, Shunsei Hirohata.   

Abstract

We report two cases presenting focal neurological deficits with high intensity lesions in fluid attenuated inversion recovery (FLAIR) images on brain magnetic resonance imaging (MRI), which almost completely improved by corticosteroid therapy. Marked elevation of cerebrospinal fluid IL-6 was also noted when these patients showed neurological deficits. As far as we explored, there have been thirteen published case reports of systemic lupus erythematosus patients with reversible focal neurological deficits. The neurological symptoms varied from case to case, but could be attributed to the lesions on MRI scans. The completely reversible feature of neurological manifestations as well as MRI findings on corticosteroid therapy is distinct from any other disorder, including cerebrovascular disease and demyelinating syndrome, in the 1999 American College of Rheumatology nomenclature. Therefore, we propose that reversible focal neurological deficits should be added to the 1999 nomenclature and classification and case definitions.

Entities:  

Mesh:

Year:  2008        PMID: 18538345     DOI: 10.1016/j.jns.2008.04.022

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study.

Authors:  Shunsei Hirohata; Yoshinori Kanai; Akiko Mitsuo; Yoshiaki Tokano; Hiroshi Hashimoto
Journal:  Clin Rheumatol       Date:  2009-07-12       Impact factor: 2.980

2.  Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders.

Authors:  Abhilash Venugopal; Raghothama Chaerkady; Akhilesh Pandey
Journal:  Ann Indian Acad Neurol       Date:  2009-01       Impact factor: 1.383

3.  Role of Serum IL-6 in Neuropsychiatric Systemic lupus Erythematosus.

Authors:  Shunsei Hirohata; Hirotoshi Kikuchi
Journal:  ACR Open Rheumatol       Date:  2021-01-03

4.  Posterior reversible encephalopathy syndrome could be an underestimated variant of "reversible neurological deficits" in Systemic Lupus Erythematosus.

Authors:  Bin Liu; Xuan Zhang; Feng-Chun Zhang; Yuan Yao; Ri-Zhi Zhou; Miao-Miao Xin; Li-Qin Wang
Journal:  BMC Neurol       Date:  2012-12-05       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.